{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:09:22Z","timestamp":1794384562671,"version":"4.9.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johannes Kepler University Linz"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiovascular manifestations are common in patients suffering axial spondyloarthritis and can result in substantial morbidity and disease burden. To give an overview of this important aspect of axial spondyloarthritis, we conducted a systematic literature search of all articles published between January 2000 and 25 May 2023 on cardiovascular manifestations. Using PubMed and SCOPUS, 123 out of 6792 articles were identified and included in this review. Non-radiographic axial spondyloarthritis seems to be underrepresented in studies; thus, more evidence for ankylosing spondylitis exists. All in all, we found some traditional risk factors that led to higher cardiovascular disease burden or major cardiovascular events. These specific risk factors seem to be more aggressive in patients with spondyloarthropathies and have a strong connection to high or long-standing disease activity. Since disease activity is a major driver of morbidity, diagnostic, therapeutic, and lifestyle interventions are crucial for better outcomes.<\/jats:p><jats:p><jats:table-wrap><jats:table><jats:tbody>\n                    <jats:tr>\n                      <jats:td align=\"left\" colspan=\"2\"><jats:bold>Key Points<\/jats:bold>\u2022 <jats:italic>Several<\/jats:italic><jats:italic> studies on axial spondyloarthritis and associated cardiovascular diseases have been conducted in the last few years addressing risk stratification of these patients including artificial intelligence<\/jats:italic>.\u2022 <jats:italic>Recent data suggest distinct manifestations of cardiovascular disease entities among men and women which the treating physician needs to be aware of<\/jats:italic>.\u2022 <jats:italic>Rheumatologists need to screen axial spondyloarthritis patients for emerging cardiovascular disease and should aim at reducing traditional risk factors like hyperlipidemia, hypertension, and smoking as well as disease activity<\/jats:italic>.<\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>","DOI":"10.1007\/s10067-023-06655-z","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T09:02:06Z","timestamp":1688720526000},"page":"2621-2633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Cardiovascular risk in axial spondyloarthritis\u2014a systematic review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-0860","authenticated-orcid":false,"given":"Rainer","family":"Hintenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0991-1189","authenticated-orcid":false,"given":"Barbara","family":"Affenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6051-0726","authenticated-orcid":false,"given":"Valeriia","family":"Vladychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0401-7849","authenticated-orcid":false,"given":"Herwig","family":"Pieringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"issue":"11","key":"6655_CR1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41584-022-00833-0","volume":"18","author":"R Stovall","year":"2022","unstructured":"Stovall R, Van Der Horst-Bruinsma IE, Liu S-H, Rusman T, Gensler LS (2022) Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis. Nat Rev Rheumatol 18(11):657\u2013669","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6655_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76(1):17\u201328","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6655_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2014-206147","volume":"75","author":"I Essers","year":"2016","unstructured":"Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F et al (2016) Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis 75(1):203\u2013209","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6655_CR4","doi-asserted-by":"crossref","first-page":"e0126347","DOI":"10.1371\/journal.pone.0126347","volume":"10","author":"WC Tsai","year":"2015","unstructured":"Tsai WC, Ou TT, Yen JH, Wu CC, Tung YC (2015) Long-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control study. PLoS One 10(5):e0126347","journal-title":"PLoS One"},{"issue":"4","key":"6655_CR5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40744-020-00233-4","volume":"7","author":"L Navarini","year":"2020","unstructured":"Navarini L, Caso F, Costa L, Currado D, Stola L, Perrotta F et al (2020) Cardiovascular risk prediction in ankylosing spondylitis: from traditional scores to machine learning assessment. Rheumatol Ther 7(4):867\u2013882","journal-title":"Rheumatol Ther"},{"issue":"6","key":"6655_CR6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3899\/jrheum.190261","volume":"47","author":"K Colaco","year":"2020","unstructured":"Colaco K, Ocampo V, Ayala AP, Harvey P, Gladman DD, Piguet V et al (2020) Predictive utility of cardiovascular risk prediction algorithms in inflammatory rheumatic diseases: a systematic review. J Rheumatol 47(6):928\u2013938","journal-title":"J Rheumatol"},{"key":"6655_CR7","first-page":"n71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA et al (2020) statement: an updated guideline for reporting systematic reviews. BMJ 2021:n71","journal-title":"BMJ"},{"issue":"3","key":"6655_CR8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"MJ Peters","year":"2004","unstructured":"Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34(3):585\u2013592","journal-title":"Semin Arthritis Rheum"},{"issue":"5474","key":"6655_CR9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/bmj.2.5474.1327","volume":"2","author":"WM Brown","year":"1965","unstructured":"Brown WM, Doll R (1965) Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J 2(5474):1327\u20131332","journal-title":"Br Med J"},{"issue":"9","key":"6655_CR10","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3899\/jrheum.090010","volume":"36","author":"MJL Peters","year":"2009","unstructured":"Peters MJL, Nielen MMJ, Raterman HG, Verheij RA, Schellevis FG, Nurmohamed MT (2009) Increased cardiovascular disease in patients with inflammatory arthritis in primary care: a cross-sectional observation. J Rheumatol 36(9):1866\u20131868","journal-title":"J Rheumatol"},{"issue":"6","key":"6655_CR11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/ard.2009.116178","volume":"69","author":"JH Kang","year":"2010","unstructured":"Kang JH, Chen YH, Lin HC (2010) Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis 69(6):1165\u20131168","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6655_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","volume":"19","author":"K Bengtsson","year":"2017","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S et al (2017) Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther. 19(1):102","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"6655_CR13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1756-185X.13970","volume":"24","author":"JH Kim","year":"2021","unstructured":"Kim JH, Choi IA (2021) Cardiovascular morbidity and mortality in patients with spondyloarthritis: a meta-analysis. Int J Rheum Dis 24(4):477\u2013486","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"6655_CR14","doi-asserted-by":"crossref","first-page":"e94027","DOI":"10.1371\/journal.pone.0094027","volume":"9","author":"CW Lin","year":"2014","unstructured":"Lin CW, Huang YP, Chiu YH, Ho YT, Pan SL (2014) Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study. PLoS One 9(4):e94027","journal-title":"PLoS One"},{"issue":"4","key":"6655_CR15","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","volume":"59","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ (2020) Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology 59(4):iv47\u2013iv57","journal-title":"Rheumatology"},{"issue":"11","key":"6655_CR16","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70(11):1921\u20131925","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6655_CR17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/acr.24820","volume":"75","author":"H Chaudhary","year":"2023","unstructured":"Chaudhary H, Bohra N, Syed K, Donato A, Murad MH, Karmacharya P (2023) All-cause and cause-specific mortality in psoriatic arthritis and ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 75(5):1052\u20131065","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"6655_CR18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.30277","volume":"63","author":"CC Mok","year":"2011","unstructured":"Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong. China Arthritis Rheum 63(5):1182\u20131189","journal-title":"China Arthritis Rheum"},{"issue":"8","key":"6655_CR19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","volume":"75","author":"S Exarchou","year":"2016","unstructured":"Exarchou S, Lie E, Lindstr\u00f6m U, Askling J, Forsblad-d\u2019Elia H, Turesson C et al (2016) Mortality in ankylosing spondylitis: results from a nationwide population-based study. Ann Rheum Dis. 75(8):1466\u201372","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"6655_CR20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N (2015) Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med 163(6):409\u2013416","journal-title":"Ann Intern Med"},{"issue":"3","key":"6655_CR21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.reuma.2022.04.001","volume":"19","author":"AS Bhagavathula","year":"2023","unstructured":"Bhagavathula AS, Bentley BL, Woolf B, Dissanayaka TD, Rahmani J (2023) Increased risk of stroke among patients with ankylosing spondylitis: a systematic review and meta-analysis. Reumatol Clin 19(3):136\u2013142","journal-title":"Reumatol Clin"},{"issue":"3","key":"6655_CR22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.autrev.2017.12.001","volume":"17","author":"KS Lee","year":"2018","unstructured":"Lee KS, Kronbichler A, Eisenhut M, Lee KH, Shin JI (2018) Cardiovascular involvement in systemic rheumatic diseases: an integrated view for the treating physicians. Autoimmun Rev 17(3):201\u2013214","journal-title":"Autoimmun Rev"},{"issue":"2","key":"6655_CR23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.semarthrit.2021.02.003","volume":"51","author":"I Gonz\u00e1lez Maz\u00f3n","year":"2021","unstructured":"Gonz\u00e1lez Maz\u00f3n I, Rueda-Gotor J, Ferraz-Amaro I, Genre F, Corrales A, Calvo Rio V et al (2021) Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients. Semin Arthritis Rheum. 51(2):395\u2013403","journal-title":"Semin Arthritis Rheum."},{"issue":"11","key":"6655_CR24","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3899\/jrheum.150316","volume":"42","author":"A Arida","year":"2015","unstructured":"Arida A, Protogerou AD, Konstantonis G, Konsta M, Delicha EM, Kitas GD et al (2015) Subclinical atherosclerosis is not accelerated in patients with ankylosing spondylitis with low disease activity: new data and metaanalysis of published studies. J Rheumatol 42(11):2098\u20132105","journal-title":"J Rheumatol"},{"issue":"1","key":"6655_CR25","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1038\/s41598-022-11640-8","volume":"12","author":"L Navarini","year":"2022","unstructured":"Navarini L, Currado D, Marino A, Di Donato S, Biaggi A, Caso F et al (2022) Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis. Sci Rep 12(1):7498","journal-title":"Sci Rep"},{"issue":"3","key":"6655_CR26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/BMR-220141","volume":"36","author":"BT Aicha","year":"2023","unstructured":"Aicha BT, Ahmed F, Seif B, Ines M, Leila R, Selma B et al (2023) Spinal radiographic progression is correlated with preclinical atherosclerosis in spondyloarthritis. J Back Musculoskelet Rehabil 36(3):701\u2013708","journal-title":"J Back Musculoskelet Rehabil"},{"key":"6655_CR27","doi-asserted-by":"crossref","first-page":"152198","DOI":"10.1016\/j.semarthrit.2023.152198","volume":"60","author":"I Ferraz-Amaro","year":"2023","unstructured":"Ferraz-Amaro I, Genre F, Blanco R, Corrales A, Maz\u00f3n IG, Portilla V et al (2023) Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients. Semin Arthritis Rheum. 60:152198","journal-title":"Semin Arthritis Rheum."},{"issue":"3","key":"6655_CR28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5551\/jat.45294","volume":"26","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Yang J, Zhang X, Han R, Chen M, Hu X et al (2019) Carotid intima-media thickness in patients with ankylosing spondylitis: a systematic review and updated meta-analysis. J Atheroscler Thromb 26(3):260\u2013271","journal-title":"J Atheroscler Thromb"},{"issue":"7\u20138","key":"6655_CR29","first-page":"455","volume":"128","author":"P Ozdowska","year":"2018","unstructured":"Ozdowska P, Wardziak \u0141, Kruk M, K\u0119pka C, Kowalik I, Szwed H et al (2018) Increased prevalence of subclinical coronary atherosclerosis in young patients with ankylosing spondylitis. Pol Arch Intern Med 128(7\u20138):455\u2013461","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"6655_CR30","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1038\/s41598-020-66816-x","volume":"10","author":"F Genre","year":"2020","unstructured":"Genre F, Rueda-Gotor J, Remuzgo-Mart\u00ednez S, Pulito-Cueto V, Corrales A, Mijares V et al (2020) Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis. Sci Rep 10(1):9636","journal-title":"Sci Rep"},{"issue":"3","key":"6655_CR31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/jcm11030766","volume":"11","author":"K Bonek","year":"2022","unstructured":"Bonek K, Kuca-Warnawin E, Kornatka A, Zieli\u0144ska A, Wis\u0142owska M, Kontny E et al (2022) Associations of IL-18 with altered cardiovascular risk profile in psoriatic arthritis and ankylosing spondylitis. J Clin Med 11(3):766","journal-title":"J Clin Med"},{"key":"6655_CR32","doi-asserted-by":"crossref","first-page":"888763","DOI":"10.3389\/fimmu.2022.888763","volume":"13","author":"M Robert","year":"2022","unstructured":"Robert M, Miossec P, Hot A (2022) The Th17 pathway in vascular inflammation: culprit or consort? Front Immunol 13:888763","journal-title":"Front Immunol"},{"issue":"11","key":"6655_CR33","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33(11):2167\u20132172","journal-title":"J Rheumatol"},{"issue":"1","key":"6655_CR34","doi-asserted-by":"crossref","first-page":"2205956","DOI":"10.1080\/08037051.2023.2205956","volume":"32","author":"G Ullensvang","year":"2023","unstructured":"Ullensvang G, Kringeland E, Ikdahl E, Provan S, Berg IJ, Rollefstad S et al (2023) Cardiovascular organ damage in relation to hypertension status in patients with ankylosing spondylitis. Blood Press 32(1):2205956","journal-title":"Blood Press"},{"issue":"1","key":"6655_CR35","doi-asserted-by":"crossref","first-page":"2205056","DOI":"10.1080\/10641963.2023.2205056","volume":"45","author":"LH Shi","year":"2023","unstructured":"Shi LH, Lam SH, So H, Chan CY, Li TK, Szeto CC et al (2023) Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: a longitudinal cohort study. Clin Exp Hypertens 45(1):2205056","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"6655_CR36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/03009742.2013.822097","volume":"43","author":"CH Chou","year":"2014","unstructured":"Chou CH, Lin MC, Peng CL, Wu YC, Sung FC, Kao CH et al (2014) A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis. Scand J Rheumatol 43(2):132\u2013136","journal-title":"Scand J Rheumatol"},{"key":"6655_CR37","doi-asserted-by":"crossref","first-page":"890543","DOI":"10.3389\/fimmu.2022.890543","volume":"13","author":"KM Feng","year":"2022","unstructured":"Feng KM, Chien WC, Chen YH, Sun CA, Chung CH, Chen JT et al (2022) Increased risk of acute coronary syndrome in ankylosing spondylitis patients with uveitis: a population-based cohort study. Front Immunol 13:890543","journal-title":"Front Immunol"},{"issue":"38","key":"6655_CR38","doi-asserted-by":"crossref","first-page":"e30811","DOI":"10.1097\/MD.0000000000030811","volume":"101","author":"CH Chen","year":"2022","unstructured":"Chen CH, Chen HA, Liao HT, Chou CT, Chen CH (2022) Association of blood pressure and hypertension with radiographic damage among the patients with ankyloing spondylitis. Medicine 101(38):e30811","journal-title":"Medicine"},{"issue":"7","key":"6655_CR39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3899\/jrheum.180538","volume":"46","author":"MH Derakhshan","year":"2019","unstructured":"Derakhshan MH, Goodson NJ, Packham JC, Sengupta R, Molto A, Marzo-Ortega H et al (2019) Increased risk of hypertension associated with spondyloarthritis disease duration: results from the ASAS-COMOSPA study. J Rheumatol 46(7):701\u2013709","journal-title":"J Rheumatol"},{"issue":"1","key":"6655_CR40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrcardio.2017.118","volume":"15","author":"E Bartoloni","year":"2018","unstructured":"Bartoloni E, Alunno A, Gerli R (2018) Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. Nat Rev Cardiol 15(1):33\u201344","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"6655_CR41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5114\/reum.2021.110610","volume":"59","author":"P Ozdowska","year":"2021","unstructured":"Ozdowska P, Kowalik I, Sadowski K, Szwed H, G\u0142uszko P, Rupi\u0144ski R et al (2021) Patterns of dyslipidemia in young patients with seronegative spondyloarthropathies without cardiovascular diseases. Reumatologia 59(5):285\u2013291","journal-title":"Reumatologia"},{"issue":"1","key":"6655_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13075-016-1148-1","volume":"18","author":"S Hassan","year":"2016","unstructured":"Hassan S, Milman U, Feld J, Eder L, Lavi I, Cohen S et al (2016) Effects of anti-TNF-\u03b1 treatment on lipid profile in rheumatic diseases: an analytical cohort study. Arthritis Res Ther 18(1):261","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"6655_CR43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10067-019-04767-z","volume":"39","author":"HK Min","year":"2020","unstructured":"Min HK, Lee J, Ju JH, Park SH, Kwok SK (2020) Impact of TNF-\u03b1 inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO). Clin Rheumatol 39(2):471\u2013477","journal-title":"Clin Rheumatol"},{"key":"6655_CR44","doi-asserted-by":"publisher","unstructured":"Masi AT, Fessler SL, Brezka ML, Wang Y, Donohue SE (2023) Systematic review and meta-analysis of individual serum lipids and analysis of lipid ratios in ankylosing spondylitis and healthy control cohorts: significantly lower mean HDL-cholesterol level in ankylosing spondylitis cohorts. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/gtcard","DOI":"10.55563\/clinexprheumatol\/gtcard"},{"issue":"1","key":"6655_CR45","doi-asserted-by":"crossref","first-page":"11548","DOI":"10.1038\/s41598-022-15436-8","volume":"12","author":"OC Kwon","year":"2022","unstructured":"Kwon OC, Han K, Chun J, Kim R, Hong SW, Kim JH et al (2022) Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study. Sci Rep 12(1):11548","journal-title":"Sci Rep"},{"issue":"2","key":"6655_CR46","first-page":"292","volume":"27","author":"JA Papadakis","year":"2009","unstructured":"Papadakis JA, Sidiropoulos PI, Karvounaris SA, Vrentzos GE, Spanakis EK, Ganotakis ES et al (2009) High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity. Clin Exp Rheumatol 27(2):292\u2013298","journal-title":"Clin Exp Rheumatol"},{"issue":"24","key":"6655_CR47","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.3390\/jcm11247330","volume":"11","author":"I Hokstad","year":"2022","unstructured":"Hokstad I, Greco D, Deyab G, Fagerland MW, Agewall S, Hjeltnes G et al (2022) Effects of antirheumatic treatment on cell cholesterol efflux and loading capacity of serum lipoproteins in spondylarthropathies. J Clin Med 11(24):7330","journal-title":"J Clin Med"},{"issue":"5","key":"6655_CR48","first-page":"261","volume":"34","author":"M Slouma","year":"2022","unstructured":"Slouma M, Ben Ali K, Kharrat L, Zouaoui C, Ouertani H, Gharsallah I (2022) Athrogenic indexes: useful markers for predicting metabolic syndrome in axial spondyloarthritis. Clin Investig Arterioscler 34(5):261\u2013268","journal-title":"Clin Investig Arterioscler"},{"issue":"2","key":"6655_CR49","first-page":"43","volume":"15","author":"S Almasi","year":"2020","unstructured":"Almasi S, Farahani B, Samiei N, Rezaei Y, Mahmoodi H, Qorbani M (2020) Echocardiographic and electrocardiographic findings in patients with ankylosing spondylitis without cardiovascular risk factors. J Tehran Heart Cent 15(2):43\u201349","journal-title":"J Tehran Heart Cent"},{"issue":"8","key":"6655_CR50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/heartjnl-2021-319603","volume":"109","author":"Y Gartshteyn","year":"2023","unstructured":"Gartshteyn Y, Bhave N, Joseph MS, Askanase A, Bernstein E (2023) Inflammatory and thrombotic valvulopathies in autoimmune disease. Heart 109(8):583\u2013588","journal-title":"Heart"},{"issue":"6","key":"6655_CR51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.14740\/jocmr2488w","volume":"8","author":"Y Ozkan","year":"2016","unstructured":"Ozkan Y (2016) Cardiac involvement in ankylosing spondylitis. J Clin Med Res 8(6):427\u2013430","journal-title":"J Clin Med Res"},{"issue":"4","key":"6655_CR52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/annrheumdis-2017-212189","volume":"77","author":"K Bengtsson","year":"2018","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S et al (2018) Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden. Ann Rheum Dis. 77(4):541\u20138","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"6655_CR53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00296-021-05040-w","volume":"42","author":"M Baniaamam","year":"2022","unstructured":"Baniaamam M, Heslinga SC, Konings TC, Handoko ML, Kamp O, van Halm VP et al (2022) Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation. Rheumatol Int 42(4):683\u2013688","journal-title":"Rheumatol Int"},{"issue":"6","key":"6655_CR54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-020-00898-4","volume":"22","author":"M Chetrit","year":"2020","unstructured":"Chetrit M, Khan MA, Kapadia S (2020) State of the art management of aortic valve disease in ankylosing spondylitis. Curr Rheumatol Rep 22(6):23","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"6655_CR55","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.amjmed.2015.04.032","volume":"128","author":"E Klingberg","year":"2015","unstructured":"Klingberg E, Sve\u00e4lv BG, T\u00e4ng MS, Bech-Hanssen O, Forsblad-d\u2019Elia H, Bergfeldt L (2015) Aortic regurgitation is common in ankylosing spondylitis: time for routine echocardiography evaluation? Am J Med 128(11):1244\u201350.e1","journal-title":"Am J Med"},{"key":"6655_CR56","doi-asserted-by":"crossref","unstructured":"Min HK, Kim HR, Lee SH, Park S, Park M, Hong YS et al (2022) Increased risks of aortic regurgitation and atrial fibrillation in radiographic axial spondyloarthritis patients: a 10-year nationwide cohort study. Ther Adv Musculoskelet Dis 14:1759720X221088094","DOI":"10.1177\/1759720X221088094"},{"issue":"1","key":"6655_CR57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10067-005-1117-6","volume":"25","author":"F Brunner","year":"2006","unstructured":"Brunner F, Kunz A, Weber U, Kissling R (2006) Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol 25(1):24\u201329","journal-title":"Clin Rheumatol"},{"key":"6655_CR58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2018.10.024","volume":"275","author":"I Moon","year":"2019","unstructured":"Moon I, Choi EK, Jung JH, Han KD, Choi YJ, Park J et al (2019) Ankylosing spondylitis: a novel risk factor for atrial fibrillation \u2014 a nationwide population-based study. Int J Cardiol 275:77\u201382","journal-title":"Int J Cardiol"},{"issue":"3","key":"6655_CR59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/europace\/euac244","volume":"25","author":"MJ Tilly","year":"2023","unstructured":"Tilly MJ, Geurts S, Zhu F, Bos MM, Ikram MA, de Maat MPM et al (2023) Autoimmune diseases and new-onset atrial fibrillation: a UK Biobank study. Europace 25(3):804\u2013811","journal-title":"Europace"},{"issue":"5","key":"6655_CR60","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1253\/circj.CJ-19-0705","volume":"84","author":"M Gawa\u0142ko","year":"2020","unstructured":"Gawa\u0142ko M, Balsam P, Lodzi\u0144ski P, Grabowski M, Krzowski B, Opolski G et al (2020) Cardiac arrhythmias in autoimmune diseases. Circ J 84(5):685\u2013694","journal-title":"Circ J"},{"issue":"3","key":"6655_CR61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2012.04.002","volume":"42","author":"HH Ho","year":"2012","unstructured":"Ho HH, Yeh SJ, Tsai WP, Wang CM, Chen JY (2012) Paroxysmal supraventricular tachycardia and Wolff-Parkinson-White syndrome in ankylosing spondylitis: a large cohort observation study and literature review. Semin Arthritis Rheum 42(3):246\u2013253","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"6655_CR62","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s10067-020-05046-y","volume":"39","author":"M Candemir","year":"2020","unstructured":"Candemir M, Candemir B, Ert\u00fcrk A (2020) Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring. Clin Rheumatol 39(9):2631\u20132639","journal-title":"Clin Rheumatol"},{"issue":"2","key":"6655_CR63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/14397595.2013.854072","volume":"24","author":"G Acar","year":"2014","unstructured":"Acar G, Yorgun H, Inci MF, Akkoyun M, Bakan B, Nacar AB et al (2014) Evaluation of Tp-e interval and Tp-e\/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol 24(2):327\u2013330","journal-title":"Mod Rheumatol"},{"issue":"2","key":"6655_CR64","doi-asserted-by":"crossref","first-page":"e001053","DOI":"10.1136\/rmdopen-2019-001053","volume":"5","author":"K Bengtsson","year":"2019","unstructured":"Bengtsson K, Klingberg E, Deminger A, Wallberg H, Jacobsson LTH, Bergfeldt L et al (2019) Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study. RMD Open 5(2):e001053","journal-title":"RMD Open"},{"issue":"12","key":"6655_CR65","first-page":"573","volume":"12","author":"U Lange","year":"2007","unstructured":"Lange U, Stapfer G, Ditting T, Geiger H, Teichmann J, M\u00fcller-Ladner U et al (2007) Pathologic alterations of the heart and the kidney in patients with ankylosing spondylitis. Eur J Med Res 12(12):573\u2013581","journal-title":"Eur J Med Res"},{"issue":"11","key":"6655_CR66","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1007\/s10067-020-05112-5","volume":"39","author":"Y Chen","year":"2020","unstructured":"Chen Y, Chan YH, Chung HY, Wu MZ, Yu YJ, Pi KL et al (2020) Cardiovascular events prediction by left ventricular longitudinal strain and serum high-sensitivity troponin I in patients with axial spondyloarthritis. Clin Rheumatol 39(11):3373\u20133382","journal-title":"Clin Rheumatol"},{"issue":"2","key":"6655_CR67","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/rheumatology\/keu337","volume":"54","author":"Y Chen","year":"2015","unstructured":"Chen Y, Chung HY, Zhao CT, Wong A, Zhen Z, Tsang HH et al (2015) Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatology 54(2):292\u2013301","journal-title":"Rheumatology"},{"issue":"1","key":"6655_CR68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5152\/eurjrheum.2019.19072","volume":"7","author":"SV Emren","year":"2020","unstructured":"Emren SV, Ger\u00e7ik O, \u00d6zdemir E, Solmaz D, Eren N, \u015eim\u015fek E et al (2020) Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. Eur J Rheumatol 7(1):9\u201315","journal-title":"Eur J Rheumatol"},{"issue":"3","key":"6655_CR69","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/jcm12031211","volume":"12","author":"TY Lin","year":"2023","unstructured":"Lin TY, Lai YF, Chien WC, Chen YH, Chung CH, Chen JT et al (2023) Impact of endophthalmitis on the risk of acute myocardial infarction in ankylosing spondylitis patients: a population-based retrospective cohort study. J Clin Med 12(3):1211","journal-title":"J Clin Med"},{"issue":"3","key":"6655_CR70","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10067-013-2444-7","volume":"33","author":"FY Gan","year":"2014","unstructured":"Gan FY, Fei YY, Li MT, Wang Q, Xu D, Hou Y et al (2014) The characteristics of patients having ankylosing spondylitis associated with Takayasu\u2019s arteritis. Clin Rheumatol 33(3):355\u2013358","journal-title":"Clin Rheumatol"},{"key":"6655_CR71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1874312901610010101","volume":"10","author":"D Ernst","year":"2016","unstructured":"Ernst D, Bearlecken N, Ernst Schmidt R, Witte T (2016) Two subsets of large vessel vasculitis characterized by the absence or presence of spondyloarthritis or its associated diseases. Open Rheumatol J 10:101\u2013108","journal-title":"Open Rheumatol J"},{"issue":"3","key":"6655_CR72","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/03009742.2013.850737","volume":"43","author":"D Ernst","year":"2014","unstructured":"Ernst D, Baerlecken NT, Schmidt RE, Witte T (2014) Large vessel vasculitis and spondyloarthritis: coincidence or associated diseases? Scand J Rheumatol 43(3):246\u2013248","journal-title":"Scand J Rheumatol"},{"key":"6655_CR73","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1874312901610010101","volume":"10","author":"D Ernst","year":"2016","unstructured":"Ernst D, Bearlecken N, Schmidt RE, Witte T (2016) Two subsets of large vessel vasculitis characterized by the absence or presence of spondyloarthritis or its associated diseases. Open Rheumatol J 10:101\u2013108","journal-title":"Open Rheumatol J"},{"issue":"3","key":"6655_CR74","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0284185121996270","volume":"63","author":"I Eshed","year":"2022","unstructured":"Eshed I, Druyan A, Stern M, Bordavka M, Lidar M (2022) The prevalence of sacroiliitis on abdominal MRI examinations of patients with Takayasu arteritis. Acta Radiol 63(3):387\u2013392","journal-title":"Acta Radiol"},{"issue":"1","key":"6655_CR75","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13075-018-1643-7","volume":"20","author":"OC Kwon","year":"2018","unstructured":"Kwon OC, Lee SW, Park YB, Oh JS, Lee SH, Hong S et al (2018) Extravascular manifestations of Takayasu arteritis: focusing on the features shared with spondyloarthritis. Arthritis Res Ther 20(1):142","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"6655_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2015.06.054","volume":"242","author":"F Ag\u00fcero","year":"2015","unstructured":"Ag\u00fcero F, Gonz\u00e1lez-Zobl G, Baena-D\u00edez JM, D\u00e9gano IR, Garcia-Gil M, Alzamora MT et al (2015) Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders. Atherosclerosis 242(1):1\u20137","journal-title":"Atherosclerosis"},{"issue":"1","key":"6655_CR77","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2021-222020","volume":"82","author":"JM Gwinnutt","year":"2023","unstructured":"Gwinnutt JM, Wieczorek M, Balanescu A, Bischoff-Ferrari HA, Boonen A, Cavalli G et al (2023) 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis 82(1):48\u201356","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6655_CR78","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3899\/jrheum.090655","volume":"37","author":"LA Passalent","year":"2010","unstructured":"Passalent LA, Soever LJ, O\u2019Shea FD, Inman RD (2010) Exercise in ankylosing spondylitis: discrepancies between recommendations and reality. J Rheumatol 37(4):835\u2013841","journal-title":"J Rheumatol"},{"issue":"2","key":"6655_CR79","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2522\/ptj.20110137","volume":"92","author":"S Halvorsen","year":"2012","unstructured":"Halvorsen S, V\u00f8llestad NK, Fongen C, Provan SA, Semb AG, Hagen KB et al (2012) Physical fitness in patients with ankylosing spondylitis: comparison with population controls. Phys Ther 92(2):298\u2013309","journal-title":"Phys Ther"},{"issue":"9","key":"6655_CR80","doi-asserted-by":"crossref","first-page":"e108688","DOI":"10.1371\/journal.pone.0108688","volume":"9","author":"SH Sveaas","year":"2014","unstructured":"Sveaas SH, Berg IJ, Provan SA, Semb AG, Hagen KB, V\u00f8llestad N et al (2014) Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study. PLoS One 9(9):e108688","journal-title":"PLoS One"},{"issue":"11","key":"6655_CR81","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3899\/jrheum.170726","volume":"45","author":"IJ Berg","year":"2018","unstructured":"Berg IJ, Semb AG, Sveaas SH, Fongen C, van der Heijde D, Kvien TK et al (2018) Associations between cardiorespiratory fitness and arterial stiffness in ankylosing spondylitis: a cross-sectional study. J Rheumatol 45(11):1522\u20131525","journal-title":"J Rheumatol"},{"issue":"1\u20132","key":"6655_CR82","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/09727531211035335","volume":"28","author":"J Singh","year":"2021","unstructured":"Singh J, Tekur P, Metri KG, Mohanty S, Singh A, Nagaratna R (2021) Potential role of Yoga in the management of ankylosing spondylitis: a retrospective study. Ann Neurosci 28(1\u20132):74\u201378","journal-title":"Ann Neurosci"},{"issue":"5","key":"6655_CR83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00296-004-0451-3","volume":"25","author":"U Kaan","year":"2005","unstructured":"Kaan U, Ferda O (2005) Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis. Rheumatol Int 25(5):357\u2013360","journal-title":"Rheumatol Int"},{"issue":"12","key":"6655_CR84","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00296-015-3381-3","volume":"35","author":"GT Sakellariou","year":"2015","unstructured":"Sakellariou GT, Anastasilakis AD, Kenanidis E, Potoupnis M, Tsiridis E, Savvidis M et al (2015) The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis. Rheumatol Int 35(12):2109\u20132114","journal-title":"Rheumatol Int"},{"issue":"7","key":"6655_CR85","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/rheumatology\/keaa093","volume":"59","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Goodson NJ, Robertson S, Gaffney K (2020) Smoking in spondyloarthritis: unravelling the complexities. Rheumatology 59(7):1472\u20131481","journal-title":"Rheumatology"},{"key":"6655_CR86","doi-asserted-by":"crossref","first-page":"792846","DOI":"10.3389\/fmed.2021.792846","volume":"8","author":"J Ciaffi","year":"2021","unstructured":"Ciaffi J, Mitselman D, Mancarella L, Brusi V, Lisi L, Ruscitti P et al (2021) The effect of ketogenic diet on inflammatory arthritis and cardiovascular health in rheumatic conditions: a mini review. Front Med 8:792846","journal-title":"Front Med"},{"issue":"6 Suppl 1","key":"6655_CR87","first-page":"e3","volume":"23","author":"FLJ Visseren","year":"2022","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M et al (2022) 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. G Ital Cardiol 23(6 Suppl 1):e3\u2013e115","journal-title":"G Ital Cardiol"},{"issue":"6","key":"6655_CR88","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10067-015-2912-3","volume":"34","author":"N Garg","year":"2015","unstructured":"Garg N, Krishan P, Syngle A (2015) Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis. Clin Rheumatol 34(6):1065\u20131071","journal-title":"Clin Rheumatol"},{"issue":"7","key":"6655_CR89","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10067-013-2233-3","volume":"32","author":"A Syngle","year":"2013","unstructured":"Syngle A, Vohra K, Khichi D, Garg N, Verma I, Kaur L (2013) Spironolactone improves endothelial dysfunction in ankylosing spondylitis. Clin Rheumatol 32(7):1029\u20131036","journal-title":"Clin Rheumatol"},{"issue":"4","key":"6655_CR90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-0040-1722738","volume":"30","author":"N Garg","year":"2021","unstructured":"Garg N, Krishan P, Syngle A (2021) Angiotensin-receptor blockade improves inflammation and endothelial dysfunction in ankylosing spondylitis: ARB-AS study. Int J Angiol 30(4):262\u2013270","journal-title":"Int J Angiol"},{"issue":"7","key":"6655_CR91","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.39114","volume":"67","author":"S Rollefstad","year":"2015","unstructured":"Rollefstad S, Ikdahl E, Hisdal J, Olsen IC, Holme I, Hammer HB et al (2015) Rosuvastatin-induced carotid plaque regression in patients with inflammatory joint diseases: the rosuvastatin in rheumatoid arthritis, ankylosing spondylitis and other inflammatory joint diseases study. Arthritis Rheumatol 67(7):1718\u20131728","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"6655_CR92","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1136\/annrheumdis-2017-211253","volume":"76","author":"A Oza","year":"2017","unstructured":"Oza A, Lu N, Schoenfeld SR, Fisher MC, Dubreuil M, Rai SK et al (2017) Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study. Ann Rheum Dis 76(10):1737\u20131742","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6655_CR93","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2012.12","volume":"25","author":"K Angel","year":"2012","unstructured":"Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D (2012) Effect of 1-year anti-TNF-\u03b1 therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens 25(6):644\u2013650","journal-title":"Am J Hypertens"},{"issue":"3","key":"6655_CR94","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00296-019-04497-0","volume":"40","author":"E V\u00e9gh","year":"2020","unstructured":"V\u00e9gh E, Kerekes G, Pusztai A, Hamar A, Szamosi S, V\u00e1ncsa A et al (2020) Effects of 1-year anti-TNF-\u03b1 therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis. Rheumatol Int 40(3):427\u2013436","journal-title":"Rheumatol Int"},{"issue":"3","key":"6655_CR95","first-page":"312","volume":"57","author":"LA Knyazeva","year":"2019","unstructured":"Knyazeva LA, Damjanov N, Knyazeva LI, Meshcherina NS, Goryainov II, Stepchenko MA et al (2019) Effect of golimumab on endothelial vasomotor function and arterial stiffness in ankylosing spondylitis. Nauchno-Prakticheskaya Revmatologiya 57(3):312\u2013317","journal-title":"Nauchno-Prakticheskaya Revmatologiya"},{"issue":"7","key":"6655_CR96","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10067-010-1402-x","volume":"29","author":"A Syngle","year":"2010","unstructured":"Syngle A, Vohra K, Sharma A, Kaur L (2010) Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade. Clin Rheumatol 29(7):763\u2013770","journal-title":"Clin Rheumatol"},{"issue":"6","key":"6655_CR97","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/rheumatology\/ket469","volume":"53","author":"LS Tam","year":"2014","unstructured":"Tam LS, Shang Q, Kun EW, Lee KL, Yip ML, Li M et al (2014) The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis-a randomized, placebo-controlled pilot trial. Rheumatology 53(6):1065\u20131074","journal-title":"Rheumatology"},{"issue":"4","key":"6655_CR98","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1472-8206.2010.00872.x","volume":"25","author":"K Angel","year":"2011","unstructured":"Angel K, Provan SA, Hammer HB, Mowinckel P, Kvien TK, Atar D (2011) Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies. Fundam Clin Pharmacol 25(4):511\u2013517","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"6655_CR99","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/rheumatology\/kes272","volume":"52","author":"S Mathieu","year":"2013","unstructured":"Mathieu S, Pereira B, Couderc M, Rabois E, Dubost J, Soubrier M (2013) No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months. Rheumatology 52(1):204\u2013209","journal-title":"Rheumatology"},{"issue":"12","key":"6655_CR100","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s00296-015-3314-1","volume":"35","author":"F Genre","year":"2015","unstructured":"Genre F, L\u00f3pez-Mej\u00edas R, Miranda-Filloy JA, Ubilla B, Mijares V, Carnero-L\u00f3pez B et al (2015) Anti-TNF-\u03b1 therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients. Rheumatol Int 35(12):2069\u20132078","journal-title":"Rheumatol Int"},{"issue":"1","key":"6655_CR101","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jbspin.2009.05.012","volume":"77","author":"S Mathieu","year":"2010","unstructured":"Mathieu S, Dubost JJ, Tournadre A, Malochet-Guinamand S, Ristori JM, Soubrier M (2010) Effects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis. Joint Bone Spine 77(1):50\u201352","journal-title":"Joint Bone Spine"},{"issue":"5","key":"6655_CR102","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","volume":"60","author":"IC van Eijk","year":"2009","unstructured":"van Eijk IC, de Vries MK, Levels JH, Peters MJ, Huizer EE, Dijkmans BA et al (2009) Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis. Arthritis Rheum 60(5):1324\u20131330","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6655_CR103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/14397595.2013.843752","volume":"24","author":"ED Ersozlu Bozkirli","year":"2014","unstructured":"Ersozlu Bozkirli ED, Bozkirli E, Yucel AE (2014) Effects of infliximab treatment in terms of cardiovascular risk and insulin resistance in ankylosing spondylitis patients. Mod Rheumatol 24(2):335\u2013339","journal-title":"Mod Rheumatol"},{"issue":"5","key":"6655_CR104","first-page":"921","volume":"33","author":"DN Kiortsis","year":"2006","unstructured":"Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA (2006) Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33(5):921\u2013923","journal-title":"J Rheumatol"},{"issue":"9894","key":"6655_CR105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA et al (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382(9894):769\u2013779","journal-title":"Lancet"},{"key":"6655_CR106","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S Trelle","year":"2011","unstructured":"Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM et al (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342:c7086","journal-title":"BMJ"},{"issue":"4","key":"6655_CR107","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40744-020-00248-x","volume":"7","author":"P Karmacharya","year":"2020","unstructured":"Karmacharya P, Shahukhal R, Crowson CS, Murad MH, Davis JM 3rd, Shrestha P et al (2020) Effects of therapies on cardiovascular events in ankylosing spondylitis: a systematic review and meta-analysis. Rheumatol Ther 7(4):993\u20131009","journal-title":"Rheumatol Ther"},{"key":"6655_CR108","doi-asserted-by":"publisher","unstructured":"Fakih O, Desmarets M, Martin B, Prati C, Wendling D, Monnet E et al (2023) Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study. Rheumatology (Oxford) kead072.\u00a0https:\/\/doi.org\/10.1093\/rheumatology\/kead072","DOI":"10.1093\/rheumatology\/kead072"},{"issue":"2","key":"6655_CR109","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.semarthrit.2019.07.012","volume":"50","author":"J Braun","year":"2020","unstructured":"Braun J, Baraliakos X, Westhoff T (2020) Nonsteroidal anti-inflammatory drugs and cardiovascular risk - a matter of indication. Semin Arthritis Rheum 50(2):285\u2013288","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"6655_CR110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/BOR.0000000000000881","volume":"34","author":"H So","year":"2022","unstructured":"So H, Tam LS (2022) Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases. Curr Opin Rheumatol 34(4):203\u2013208","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"6655_CR111","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/1756-185X.12986","volume":"20","author":"HW Tam","year":"2017","unstructured":"Tam HW, Yeo KJ, Leong PY, Chen CH, Li YC, Ma CM et al (2017) Sulfasalazine might reduce risk of cardiovascular diseases in patients with ankylosing spondylitis: a nationwide population-based retrospective cohort study. Int J Rheum Dis 20(3):363\u2013370","journal-title":"Int J Rheum Dis"},{"issue":"36","key":"6655_CR112","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1097\/MD.0000000000004792","volume":"95","author":"LC Wu","year":"2016","unstructured":"Wu LC, Leong PY, Yeo KJ, Li TY, Wang YH, Chiou JY et al (2016) Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: a nation-wide, population-based case-control study. Medicine 95(36):e4792","journal-title":"Medicine"},{"key":"6655_CR113","doi-asserted-by":"crossref","first-page":"1759720x2110324","DOI":"10.1177\/1759720X211032444","volume":"13","author":"SCW Chan","year":"2021","unstructured":"Chan SCW, Teo CK, Li PH, Lau KK, Lau CS, Chung HY (2021) Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs. Ther Adv Musculoskelet Dis. 13:1759720x211032444","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"1","key":"6655_CR114","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","volume":"20","author":"JL Lee","year":"2018","unstructured":"Lee JL, Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L (2018) Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. Arthritis Res Ther 20(1):171","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"6655_CR115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13075-022-02836-4","volume":"24","author":"OC Kwon","year":"2022","unstructured":"Kwon OC, Park MC (2022) Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis. Arthritis Res Ther 24(1):141","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"6655_CR116","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMe2117663","volume":"386","author":"JA Singh","year":"2022","unstructured":"Singh JA (2022) Risks and benefits of Janus kinase inhibitors in rheumatoid arthritis - past, present, and future. N Engl J Med 386(4):387\u2013389","journal-title":"N Engl J Med"},{"issue":"4","key":"6655_CR117","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL et al (2022) Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med 386(4):316\u2013326","journal-title":"N Engl J Med"},{"issue":"1","key":"6655_CR118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D et al (2023) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 82(1):3\u201318","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6655_CR119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"6655_CR120","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.3390\/jcm11236894","volume":"11","author":"A Makris","year":"2022","unstructured":"Makris A, Barkas F, Sfikakis PP, Liberopoulos E, Agouridis AP (2022) The effect of upadacitinib on lipid profile and cardiovascular events: a meta-analysis of randomized controlled trials. J Clin Med 11(23):6894","journal-title":"J Clin Med"},{"issue":"3","key":"6655_CR121","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10067-022-06471-x","volume":"42","author":"G Evangelatos","year":"2023","unstructured":"Evangelatos G, Fragoulis GE (2023) JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know. Clin Rheumatol 42(3):959\u2013962","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06655-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06655-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06655-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:09:21Z","timestamp":1699884561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06655-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":121,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6655"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06655-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}